← Every applicant
Dexcel FDA Approvals
5 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| NINTEDANIB ESYLATENew drugApr 2, 2026CAPSULE, ORAL |
| TOFACITINIB CITRATENew drugDec 16, 2024TABLET, EXTENDED RELEASE, ORAL |
| PANTOPRAZOLE SODIUMNew drugJun 16, 2023FOR SUSPENSION, DELAYED RELEASE, ORAL |
| OMEPRAZOLE MAGNESIUMNew drugMay 24, 2022CAPSULE, DELAYED RELEASE, ORAL |
| VIGABATRINNew drugSep 23, 2021TABLET, ORAL |